Description
Dr. Arjun Srivastav Rybelsus is an oral prescription medicine that contains the active ingredient semaglutide. It is registered in Australia for the treatment of adults with insufficiently controlled type 2 diabetes mellitus, used as an adjunct to diet and exercise.
The 14 mg tablet represents one particular strength within the Rybelsus range, which also includes 3 mg and 7 mg tablets. Treatment selection, dose escalation and any changes to the prescribed regimen require the guidance of a qualified prescriber.
This page provides verified product information based on current Australian sources. It does not substitute for professional medical advice.
Rybelsus 14 mg: Product Information
| Product detail | Information |
|---|---|
| Brand name | Rybelsus |
| Active ingredient | Semaglutide |
| Strength | 14 mg |
| Dosage form | Oral tablet |
| Therapeutic use | Treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise |
| Administration | Once daily on an empty stomach, swallowed whole with up to 120 ml of water, with at least 30 minutes before food, drinks or other oral medicines |
| Prescription status | Schedule 4 Prescription Only Medicine in Australia |
These details are drawn from the current Australian Product Information and the Therapeutic Goods Administration register entry. Pack sizes, pricing and supply availability can change over time and should be confirmed with a pharmacist or the prescriber.
What Is Rybelsus 14 mg?
Semaglutide belongs to a class of medicines known as glucagon like peptide 1 receptor agonists, often shortened to GLP 1 receptor agonists. These medicines work by mimicking the activity of a naturally occurring hormone that helps regulate blood glucose levels.
Semaglutide is produced through recombinant DNA technology and is classified as a biological medicine. What sets Rybelsus apart from other semaglutide formulations is its oral tablet form.
Other semaglutide products available in Australia are administered by injection, whereas Rybelsus is taken by mouth once daily. This delivery method was developed to provide an alternative for adults who may prefer an oral option. It comes with specific administration requirements that affect how the medicine is absorbed.
Because Rybelsus acts on glucose regulation and can interact with other diabetes medicines, it should only be used under medical supervision. A prescriber determines whether it is appropriate for an individual based on their full clinical picture.
What Is Rybelsus 14 mg Used For?
Rybelsus is indicated in Australia for the treatment of adults with insufficiently controlled type 2 diabetes mellitus. It is used as an adjunct to diet and exercise, meaning it is intended to support rather than replace lifestyle measures that form the foundation of diabetes management.
The medicine may be prescribed as monotherapy when metformin is considered inappropriate due to intolerance or contraindications. It can also be used in combination with other glucose lowering medicinal products for the treatment of type 2 diabetes.
The intended patient population is adults whose blood glucose levels have not been adequately controlled by diet, exercise and existing treatments. A clinician determines whether treatment is appropriate by reviewing individual blood glucose readings, current medications, kidney and liver function, and overall health status.
Diet and exercise remain important parts of type 2 diabetes management, and understanding the role of nutrition can provide useful context when developing an individual care plan. Read more about diet and exercise in diabetes management.
Rybelsus should not be presented as a substitute for an individualised diabetes management plan. Diet, physical activity, blood glucose monitoring and regular review with a healthcare professional all remain central to effective care. It is also important to distinguish between an approved indication and an unapproved or off label use. The Australian approval covers type 2 diabetes management only, and any use outside this approved indication should be discussed with the treating clinician.
How Does Rybelsus 14 mg Work?
Rybelsus works by activating the GLP 1 receptor, which is involved in several glucose dependent processes that help regulate blood sugar. When blood glucose levels rise, such as after eating, this receptor activation stimulates the pancreas to release insulin.
Because this effect is glucose dependent, the medicine promotes insulin secretion when blood glucose is elevated and reduces this activity as glucose levels return toward normal. At the same time, semaglutide suppresses the secretion of glucagon, a hormone that normally raises blood glucose.
By reducing glucagon output when appropriate, the medicine helps limit excess glucose production by the liver. Semaglutide also slows gastric emptying, which can affect how quickly food passes through the stomach, and may influence appetite.
Individual responses to Rybelsus can differ based on factors such as diet, activity level, other medications and each person unique physiology. The medicine is not associated with immediate or guaranteed effects on glucose control. Ongoing monitoring with a healthcare professional remains essential.
🔵 Reminder
How to Take Rybelsus 14 mg
Rybelsus is taken as a single tablet once daily. The prescribed dosing schedule follows a stepped approach. Treatment begins with the 3 mg tablet once daily for one month, after which the dose is increased to the 7 mg maintenance tablet once daily.
After at least one month on the 7 mg dose, the prescriber may increase the dose to the 14 mg maintenance tablet once daily to further improve glycaemic control. The maximum recommended single daily dose is 14 mg. Taking two 7 mg tablets to achieve the effect of a 14 mg dose has not been studied and is not recommended.
Rybelsus should be taken on an empty stomach. The tablet must be swallowed whole with up to half a glass of plain water, equivalent to 120 ml. It should not be split, crushed or chewed.
After taking the tablet, the patient should wait at least 30 minutes before the first meal or drink of the day or before taking other oral medicines. Waiting less than 30 minutes may decrease the absorption of semaglutide. Rybelsus should not be taken with any liquid other than plain water.
If a dose is missed, the missed dose should be skipped and the next dose taken the following day. Patients should not take an extra tablet to make up for a missed one. Any dose adjustment is a clinical decision made by the treating healthcare professional based on blood glucose response and individual circumstances.
💡 Tip
Rybelsus 14 mg Side Effects
Like all medicines, Rybelsus can cause side effects, though not everyone will experience them. The information below is based on the current Australian Product Information and is presented to help patients recognise effects that may warrant attention.
This information does not imply that everyone will experience these effects, nor does the absence of symptoms guarantee that no adverse reaction is occurring. Patients should discuss any concerns with their prescriber or pharmacist.
⚠️ Warning
Who Should Avoid Rybelsus 14 mg or Use It With Caution?
Rybelsus is not suitable for everyone. The medicine is contraindicated in individuals with known hypersensitivity to semaglutide or to any of the excipients in the tablet. Anyone who has previously experienced an allergic reaction to the medicine should not take it.
Several medical conditions require additional assessment before treatment begins. Rybelsus should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis. There is limited therapeutic experience in patients with severe renal impairment, and the medicine is not recommended for those with end stage renal disease.
Caution is also advised in patients with severe hepatic impairment. The medicine is not recommended in patients with congestive heart failure classified as New York Heart Association class IV. There is no therapeutic experience in patients who have undergone bariatric surgery. Caution should be exercised in patients with a history of pancreatitis.
When Rybelsus is used in combination with a sulfonylurea or insulin, the risk of hypoglycaemia may increase. A reduction in the dose of the sulfonylurea or insulin may be considered. Patients taking other medicines that affect blood glucose should discuss these with their prescriber, as monitoring may be needed.
Regarding pregnancy, Rybelsus should be discontinued if pregnancy occurs and should be discontinued at least two months before a planned pregnancy due to the long half life of semaglutide. The medicine should not be used during breastfeeding, as a risk to a breastfed child cannot be excluded. Women who are pregnant, planning pregnancy or breastfeeding should discuss their options with their treating clinician.
🚨 Important
Rybelsus 14 mg and Weight Loss
Some people search for information about Rybelsus 14 mg and weight loss, particularly asking how much weight can you lose on rybelsus 14 mg. It is important to distinguish between changes in body weight that have been observed during diabetes treatment and an approved indication for weight management.
In Australia, Rybelsus is approved for the treatment of type 2 diabetes, not for weight management. While changes in body weight have been reported in clinical trials of semaglutide, these observations occurred in the context of diabetes treatment and cannot be used to predict what any individual will experience.
Weight changes differ between people and are influenced by many factors, including diet, activity level, other medications and individual physiology. Results from clinical trials reflect group averages across study populations and cannot be applied as a guarantee to any single person.
Rybelsus 14 mg should not be described as a guaranteed weight loss treatment, and no numerical weight loss promise is appropriate. A prescriber should assess the suitability of treatment based on the individual clinical circumstances, and any questions about weight in relation to diabetes management should be discussed with the treating healthcare professional.
People managing type 2 diabetes may also have questions about sustainable lifestyle changes and body weight. This guide to weight management when living with diabetes provides additional context on the topic.
Is Rybelsus 14 mg Discontinued?
Questions about whether Rybelsus 14 mg has been discontinued are common, particularly from people who have had difficulty obtaining the medicine. Rather than relying on informal reports, the most reliable way to verify the current status is through official Australian sources.
The Therapeutic Goods Administration maintains the Australian Register of Therapeutic Goods, which lists medicines registered for supply in Australia. Checking the ARTG entry for Rybelsus can confirm whether the product remains registered.
It is important to distinguish between a product registration status, temporary supply disruptions, availability at a particular pharmacy, and changes to packaging or product information. A medicine can remain registered while experiencing intermittent supply issues, and local pharmacy stock can vary.
Without current verified evidence, this page does not claim that Rybelsus 14 mg has been discontinued or that it is widely available. Patients who are prescribed Rybelsus and are having trouble accessing it should speak with their pharmacist, who can check supply through official channels and discuss alternatives with the prescriber if needed.
Storing Rybelsus 14 mg
Rybelsus tablets should be stored below 30 degrees Celsius. The medicine should be kept in its original blister package to protect it from moisture and light. Keeping the tablets in their original packaging until use helps maintain their quality and effectiveness.
The expiry date can be found on the packaging and should be checked before use. Tablets should be kept out of reach of children. Any unused medicine or waste material should be disposed of by taking it to a local pharmacy rather than discarding it in household waste. Patients with questions about storage can speak with their pharmacist for guidance.
Where Can You Buy Rybelsus 14 Mg In Australia?
Get the best and fair price on buying the Rybelsus 14 mg on the online pharmacy approved by the FDA, AustraliaRXMeds.
It is the most trusted name in Australia, while online pharmacies are recommended.
FAQs
What is Rybelsus 14 Mg used for?
Rybelsus 14 Mg is used to help control blood sugar levels in adults with type 2 diabetes along with diet and exercise.
What does Rybelsus 14 Mg contain?
It contains Semaglutide, a GLP-1 receptor agonist that helps improve blood sugar control.
How to take Rybelsus 14 mg?
Take one tablet daily on an empty stomach with up to 120 ml of plain water, then wait at least 30 minutes before eating, drinking or taking other oral medicines. The dose is increased gradually by the prescriber from 3 mg to 7 mg to 14 mg, and a missed dose should be skipped until the next day.
How long does Rybelsus 14 Mg stay active?
The medicine works throughout the day, and Semaglutide may remain in the body for about a week due to its long half-life.
How much weight can you lose on Rybelsus 14 mg?
Individual weight changes vary and cannot be predicted for any one person. Rybelsus is not approved for weight management in Australia, and any questions about weight should be discussed with a prescribing clinician.
Can I take Rybelsus 14 Mg with other diabetes medicines?
It may be used with other diabetes medications if prescribed by a healthcare provider. Always follow your doctor’s advice.
What should I avoid while taking Rybelsus 14 Mg?
Avoid skipping meals excessively, alcohol overuse, and changing your dosage without medical guidance.
How should Rybelsus 14 Mg be stored?
Store it at room temperature in a cool, dry place away from moisture and direct sunlight.
Is Rybelsus 14 mg discontinued?
Current registration and supply status can be verified through the Therapeutic Goods Administration and the Australian Register of Therapeutic Goods. This page does not make an unverified claim about discontinuation, so patients should ask their pharmacist or prescriber for current information.
Where can I find reliable information about Rybelsus 14 mg?
Reliable information is available from the Therapeutic Goods Administration, the Australian Product Information and the Consumer Medicine Information. The treating healthcare professional or pharmacist is also an important source of guidance tailored to individual circumstances.
No reviews yet.